Clinical Trial Update: Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Gene Mutations [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for Rucaparib in patients with metastatic hormone-sensitive prostate cancer harboring germline DNA repair gene mutations…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• RUBRACA (RUCAPARIB)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Prostate Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2024-10-16